<DOC>
	<DOC>NCT01475682</DOC>
	<brief_summary>Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.</brief_summary>
	<brief_title>Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea</brief_title>
	<detailed_description>1. Primary outcome: Incidence of cardiometabolic diseases in subjects with OSA over 9 years. 2. Secondary outcomes: Effects of CPAP treatment on cardiometabolic conditions</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>From previous cohort for reassessment. Unstable medical conditions</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>cardiometabolic complications</keyword>
	<keyword>Effects of CPAP treatment</keyword>
</DOC>